Director, Corporate Accounting

Generate Biomedicines•Somerville, MA

10h•$177,000 - $266,000•Hybrid

About The Position

We are seeking a highly collaborative and hands-on Director, Corporate Accounting to lead the Company’s core accounting operations as we transition to life as a public biotechnology company with an ongoing Phase 3 clinical trial. This role will oversee the general ledger, monthly close, and financial reporting support processes while building scalable infrastructure to support public company requirements. The Director will play a key role in strengthening internal controls, participating in the build-out of SOX compliance, and enhancing the effectiveness of our ERP and close-related systems. We are seeking a forward-thinking leader who embraces technology, automation, and emerging AI-enabled capabilities to drive scalability, strengthen controls, improve operational efficiency, and enable a more data-driven accounting organization. This leader will manage a small team and must combine strong technical expertise with a detail-oriented, roll-up-your-sleeves approach and a mindset focused on process optimization, system leverage, and continuous improvement.

Requirements

Bachelor’s degree in Accounting or Finance; CPA strongly preferred.
10+ years of progressive accounting experience, including public company or pre-IPO experience.
Strong understanding of U.S. GAAP and general ledger accounting processes.
Experience with NetSuite required; familiarity with close management and ancillary financial systems preferred.
Experience participating in SOX implementation or operating in a SOX-compliant environment.
Demonstrated leadership experience managing and developing direct reports.
Highly detail-oriented with strong analytical and problem-solving skills.
Ability to operate effectively in a fast-paced, evolving environment.

Nice To Haves

Big 4 public accounting experience preferred.
Experience in biotechnology, life sciences, or R&D-intensive environments preferred.

Responsibilities

Lead the monthly, quarterly, and annual close processes, ensuring timely, accurate, and well-documented financial results, including oversight of the general ledger, journal entries, account reconciliations, accruals, and variance analysis.
Manage and develop a high-performing accounting team by providing mentorship, structure, accountability, and opportunities for professional growth within a collaborative environment.
Build and scale accounting processes, systems, and controls to support the Company’s evolution as a newly public biotech company, including optimization of NetSuite and related close/reporting tools to enhance automation, reporting capabilities, workflow efficiency, and data integrity.
Champion the evaluation and adoption of technology, automation, and AI-enabled solutions that enhance the effectiveness, scalability, and efficiency of accounting processes, internal controls, financial reporting support, and close activities, while maintaining appropriate governance, accuracy, and compliance standards.
Partner cross-functionally with FP&A, Clinical Operations, R&D, Procurement, and Legal to ensure accurate accounting for clinical trial expenses and other key operational activities, including leading the Phase 3 clinical trial accrual process and related financial analyses.
Support SEC reporting and public company compliance requirements in collaboration with the technical accounting and SEC reporting teams, including the design and implementation of ICFR and SOX-compliant processes and documentation.
Ensure audit readiness and serve as a key liaison with external auditors to support quarterly reviews, annual audits, and continuous process improvements across the accounting function.